IL-1β receptor antagonist reduces inflammation in hemodialysis patients - Wikidata - awgldk - TriplyDB

IL-1β receptor antagonist reduces inflammation in hemodialysis patients

IL-1β receptor antagonist reduces inflammation in hemodialysis patients

http://www.wikidata.org/entity/Q34695324

about

Recent advances in the management of hemodialysis patients: a focus on cardiovascular disease Inflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son".Immunosuppressive Medications.Circulatory mitochondrial DNA is a pro-inflammatory agent in maintenance hemodialysis patients.Mechanisms of muscle wasting in chronic kidney disease Chronic Inflammation and Coronary Atherosclerosis in Patients with End-Stage Renal Disease Optimal nutrition in hemodialysis patients.Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder.The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.Treating inflammation by blocking interleukin-1 in humans.Dialysis in 2011: Can cardiovascular risk in dialysis patients be decreased?Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis.Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled.Can treating persistent inflammation limit protein energy wasting?Haemodialysis-induced hypoglycaemia and glycaemic disarrays.Muscle-Derived IL-6 Is Not Regulated by IL-1 during Exercise. A Double Blind, Placebo-Controlled, Randomized Crossover Study.Oxalate, inflammasome, and progression of kidney disease Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease.Inflammasome Activation in Chronic Glomerular Diseases.Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations.Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass.Cardiovascular disease in haemodialysis: role of the intravascular innate immune system.Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1.Fever of unknown origin in a haemodialysis patient: a late diagnosis requiring a novel treatment.Factors Associated with Frailty and Its Trajectory among Patients on Hemodialysis.NF-κB expression and its association with nutritional status in hemodialysis patients.Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protoc Angiotensin II, via angiotensin receptor type 1/nuclear factor-κB activation, causes a synergistic effect on interleukin-1-β-induced inflammatory responses in cultured mesangial cells.Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study.Statin use is associated with lower inflammation and erythropoietin responsiveness index in hemodialysis patients.Inflammation as a Therapeutic Target To Improve Vascular Function in Kidney Disease.IL-1 Inhibition and Vascular Function in CKD.Malnutrition in Dialysis Patients--The Need for Intervention Despite Uncertain Benefits.Administration of IL-1ra improves adiponectin levels in chronic hemodialysis patients.Targeting Immunity in End-Stage Renal Disease.Endothelial dysfunction, inflammation and malnutrition markers as predictors of mortality in dialysis patients: multimarker approach.C-reactive Protein: Repeated Measurements will Improve Dialysis Patient Care.Does inflammation affect outcomes in dialysis patients?Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).

P2860

Q26849298-226865C1-7ED0-4E16-9BE1-640B345ABDF6 Q33611989-5F39F889-7676-4982-95B2-3CD95F0B4297 Q34484801-7FE75997-7821-4B08-A7B0-220DA3D03A96 Q34653708-B485034F-5CA2-4BAA-9B87-A1C6C1564159 Q34723810-8BAEC34C-8E1E-4CA5-BE80-B554D680386C Q36036008-2C61535A-4AFA-4BB3-837F-5F1A97EB6E3C Q36640685-64822359-BA24-4BFB-B00B-BB02AD2490C0 Q36816872-C0A1D789-8164-4C56-9B27-D16DB946A30E Q37136385-42CAD841-34C6-4AAC-BD45-E937E79004CD Q37186953-CC6F86FF-7016-417C-BEDF-A778903662EF Q37636664-00FEC432-510A-434D-B040-08FAEC1E7A1B Q37967084-1C221451-E7E7-4A96-8543-89CDF2D1A2BC Q38042223-45E46E94-7206-4C35-ACCF-C8598E374852 Q38042361-94EAF7EF-0CDF-4522-912E-4550F6D1D39C Q38050186-B0252D99-4C3F-490B-9EA4-F718AEF3C8F5 Q38409082-170B6B00-1BA4-415C-99D1-F8141A4CA109 Q38829506-D09E71F1-B5C0-4526-99D6-A866B147FCBC Q38837256-1B6A3C7F-51DF-4D07-AB80-007C9CE86703 Q38925521-D4DFF5AE-6252-4A63-915E-577E04B1692B Q38931056-066C527A-A0B7-4160-B738-4A67D7214789 Q39084627-300414CA-4EF9-49F4-A96A-BE9AAF2C5764 Q39099310-B4FE65F8-F1CC-4062-8AB3-C0DF81968A0F Q39151839-B690F8A9-6238-45A3-939D-111516B3FEF0 Q39466056-4398C1D4-E35D-4BAF-999A-D2B580624908 Q40161734-01D9A458-00EA-4084-9940-C7BB0806D790 Q40174639-3D4B9C09-BF3D-4822-8084-B42DFC99E478 Q40563733-105137D4-99F8-4E0F-8C29-568839E4CC18 Q41581182-1B072873-D4D1-4AA5-B4CA-2C849416A375 Q42690770-C0366479-12FD-4903-A211-9D7CC8A49678 Q44168285-E253D57B-D071-4861-8D10-B98C8E4F964D Q44976787-57372F5D-C8FC-478C-9667-19B86ED37AA5 Q48001040-6281EEBD-6F3C-4E11-A247-3A97A7E3BFD5 Q48040831-5DC832E3-01CE-44E7-A104-2852E601998A Q48077990-2515ACD8-2F19-419D-88AB-EEACD757225F Q48338769-7C255BAB-C908-48B7-97F5-0B8BD9BCD74F Q50872135-54243C97-C18F-4B16-BB79-637E46FE80CD Q51065329-BA991A99-032B-4ACB-B25C-AF0DC8C5C7F3 Q51723059-D787FD26-A82D-4CB3-ADEF-8C3B27748A1D Q52669320-333D80C8-7096-444C-9A7F-7995176BBA8B Q55476982-E35C6A1E-0E74-4BD7-9DAE-5626BB15C16A

P2860

IL-1β receptor antagonist reduces inflammation in hemodialysis patients

http://www.wikidata.org/entity/Q34695324

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

IL-1β receptor antagonist reduces inflammation in hemodialysis patients

@ast

IL-1β receptor antagonist reduces inflammation in hemodialysis patients

@en

IL-1β receptor antagonist reduces inflammation in hemodialysis patients

@nl

type

label

IL-1β receptor antagonist reduces inflammation in hemodialysis patients

@ast

IL-1β receptor antagonist reduces inflammation in hemodialysis patients

@en

IL-1β receptor antagonist reduces inflammation in hemodialysis patients

@nl

prefLabel

IL-1β receptor antagonist reduces inflammation in hemodialysis patients

@ast

IL-1β receptor antagonist reduces inflammation in hemodialysis patients

@en

IL-1β receptor antagonist reduces inflammation in hemodialysis patients

@nl

P1433

Q34695324-DBDD4FBC-D016-466B-88EC-D51EC2DBB187

P1476

Q34695324-8F4E6628-57B5-408E-858F-E808EB5E96E7

P2093

Q34695324-5C7CED5A-E9D3-485A-B953-EDC376C89E63

Q34695324-6FE24BA6-2DE3-400F-A00C-E7EC0ED9CC85

Q34695324-F19CBC14-5562-42E2-A9BF-ED471D671DE4

Q34695324-F1B5EBC3-DE08-4E3A-B8E7-40641694120F

Q34695324-F6DD2C19-6826-4AA2-90FB-DD09D303386C

P2860

Q34695324-03D974EA-25C2-427F-8B38-F674F5E50AD5

Q34695324-1CC07B97-F647-4899-850C-5685F9098E4F

Q34695324-1F22834E-1B42-4CB6-B090-E53B9C741EB7

Q34695324-2B15193B-6347-47EF-8AE3-86B86DC7763F

Q34695324-2B22A2D9-C485-4461-9CFE-F45A1CA5E489

Q34695324-3263B305-7CE5-4EA1-9539-078606C5B52C

Q34695324-38A12E3F-59A0-4889-B2F3-45922A6B4796

Q34695324-3F125CB5-273B-404F-AB28-56426136445F

Q34695324-49151753-E552-486A-9D3F-C6386F790552

Q34695324-4B4F7CAD-5576-460A-8210-EA6AFF9BE6E6

P304

Q34695324-95F5BBE6-1925-464E-9FBB-81F443207AFA

P31

Q34695324-4ABFBE4F-DB6E-4189-9AE9-9AD8A7C63186

P356

Q34695324-D6DDC44A-FD50-4429-B9A1-2962AA48EA6C

P433

Q34695324-C1566517-7716-49C3-BA60-90E18F327ACA

P478

Q34695324-C2CA19A1-71E5-4E65-9EE2-E80E003E8861

P577

Q34695324-756213AA-C39E-4C3E-A835-F1ABF8949859

P698

Q34695324-20BB6BE6-D5F5-4397-A766-E90729D0F690

P921

Q34695324-4F2B35AC-4252-4B52-A754-A0B2954786C2

Q34695324-5DDDA421-0A8E-48FD-BB16-7D17025CE9EB

P932

Q34695324-DC7E9E6B-960E-4171-9C5B-65AA84CB11EC

P356

P1433

Journal of the American Society of Nephrology

P1476

IL-1β receptor antagonist reduces inflammation in hemodialysis patients

@en

P2093

Adriana M Hung

http://www.w3.org/2001/XMLSchema#string

Ayumi Shintani

http://www.w3.org/2001/XMLSchema#string

Charles D Ellis

http://www.w3.org/2001/XMLSchema#string

Cindy Booker

http://www.w3.org/2001/XMLSchema#string

T Alp Ikizler

http://www.w3.org/2001/XMLSchema#string

P2860

Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.

Gout-associated uric acid crystals activate the NALP3 inflammasome

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

Excerpts from the US Renal Data System 2009 Annual Data Report.

Inflammatory markers and the risk of coronary heart disease in men and women.

Anemia of chronic disease.

Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.

Inflammation in end-stage renal disease: sources, consequences, and therapy.

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.

Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines.

P304

437-442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2010070760

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21310819

http://www.w3.org/2001/XMLSchema#string

P921

P932

3060437

http://www.w3.org/2001/XMLSchema#string